Metraipolis › archive › dc_e015fbd3a61e

TLR2, CCR1, IRF8, and CCL4 as biomarkers for atherosclerosis progression and therapy response: A multi-omics study — Europe PMC PMID:41465914

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41465914
DOI
10.1097/md.0000000000046647
License (as archived)
solo-consultazione
Archived
2026-10-15T18:00:10.163Z
SHA-256 of the archived text
06732835f29b478f6621bcc246707b6224308e89f54f857f5f421963d8153554
Stable URL of this page
https://metraipolis.com/documento/dc_e015fbd3a61e

How to cite

TLR2, CCR1, IRF8, and CCL4 as biomarkers for atherosclerosis progression and therapy response: A multi-omics study — Europe PMC PMID:41465914 — Europe PMC (en), https://europepmc.org/article/MED/41465914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e015fbd3a61e (Metraipolis archive dc_e015fbd3a61e, sha256 06732835f29b478f6621bcc246707b6224308e89f54f857f5f421963d8153554)
BibTeX
@misc{dce015fbd3a61e,
  title = {TLR2, CCR1, IRF8, and CCL4 as biomarkers for atherosclerosis progression and therapy response: A multi-omics study — Europe PMC PMID:41465914},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465914},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e015fbd3a61e; sha256 06732835f29b478f6621bcc246707b6224308e89f54f857f5f421963d8153554},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465914. Agents can read the archived copy with the MCP tool read_document.